Canada Pension Plan Investment Board
ALLO icon

Canada Pension Plan Investment Board’s Allogene Therapeutics ALLO Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Buy
+115,500
New +$254K ﹤0.01% 1545
2026
Q1 		– Sell
-38,200
Closed -$52.3K – 1697
2025
Q4 		$52.3K Buy
+38,200
New +$50.4K ﹤0.01% 1888

Other funds holding ALLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Canada Pension Plan Investment Board's ALLO Position: Q2 2026 in Review

Canada Pension Plan Investment Board opened a new position in Allogene Therapeutics (ALLO) in Q2 2026: 115,500 shares worth $240K. The stake represents ﹤0.01% of the portfolio and ranks #1545 among its holdings. This is a return to the name: Canada Pension Plan Investment Board previously reported a position in ALLO as recently as Q4 2025.

Canada Pension Plan Investment Board first reported a position in ALLO in Q4 2025 and has held it in 2 quarters since. 209 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

  • Canada Pension Plan Investment Board held 115,500 shares of Allogene Therapeutics worth $240K as of Q2 2026.
  • Allogene Therapeutics was a new Canada Pension Plan Investment Board position in Q2 2026.
  • Allogene Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1545 holding.
  • Canada Pension Plan Investment Board first reported a position in Allogene Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 209 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.